E Gluckman

Summary

Country: Germany

Publications

  1. ncbi request reprint High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome
    G Kogler
    José Carreras EUROCORD NETCORD Bank Germany at the Institute for Transplantation Diagnostics and Cell Therapeutics, University of Duesseldorf Medical School, Dusseldorf, Germany
    Bone Marrow Transplant 36:1033-41. 2005
  2. ncbi request reprint Effect of tresperimus on ex vivo expansion of CD34+CD38(-)-enriched cord blood cells
    S el Marsafy
    Laboratoire de Recherche sur la Biologie de la Moelle Osseuse, Institut Universitaire d Hematologie, EA 1814 Paris VII, Hopital Saint Louis, 1, avenue Claude Vellefaux, 75475 Paris, France
    Haematologia (Budap) 32:327-36. 2002
  3. ncbi request reprint Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia
    V Rocha
    Eurocord-Cord Blood Transplant Group (CBTG) and Biostatistics Department, Saint Louis Hospital AP-HP, University of Paris 7, France
    Blood 97:2962-71. 2001
  4. ncbi request reprint Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia
    J R Passweg
    Department Innere Medizin, Kantonsspital, Basel, Switzerland
    Bone Marrow Transplant 37:641-9. 2006
  5. ncbi request reprint History of the clinical use of umbilical cord blood hematopoietic cells
    E Gluckman
    Department of Hematology, Bone Marrow Transplant and Eurocord Netcord Registry, Hospital Saint Louis, Paris, France
    Cytotherapy 7:219-27. 2005
  6. ncbi request reprint HLA-G mRNA forms in human trophoblasts and peripheral blood lymphocytes: potential use in prenatal diagnosis
    P Moreau
    CEA DSV DPTE, Laboratoire d Immunoradiobiologie, Hopital Saint Louis, Centre Hayem, Paris, France
    Folia Biol (Praha) 40:431-8. 1994
  7. ncbi request reprint Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders
    H Bittencourt
    Bone Marrow Transplant Unit, Hospital Saint Louis, Paris, France
    Bone Marrow Transplant 36:431-5. 2005
  8. ncbi request reprint A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors
    M Robin
    Service d hématologie greffe de moelle, Hopital Saint Louis, APHP, Paris, Cedex, France
    Leukemia 19:1613-20. 2005
  9. ncbi request reprint Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients
    R Peffault de Latour
    Service d hématologie greffe de moelle osseuse, et Université Paris VII, Hopital Saint Louis, Paris Cedex, France
    Bone Marrow Transplant 36:709-13. 2005
  10. ncbi request reprint Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry
    J Donadieu
    Service d hématologie et oncologie pédiatrique, Hopital Trousseau, Paris, France
    Bone Marrow Transplant 36:787-92. 2005

Collaborators

Detail Information

Publications26

  1. ncbi request reprint High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome
    G Kogler
    José Carreras EUROCORD NETCORD Bank Germany at the Institute for Transplantation Diagnostics and Cell Therapeutics, University of Duesseldorf Medical School, Dusseldorf, Germany
    Bone Marrow Transplant 36:1033-41. 2005
    ..01). No significant correlation was found between numbers of HLA-MM on the HR level with 2-year survival. The analysis shows that the degree of mismatching in UCBT is even higher than expected...
  2. ncbi request reprint Effect of tresperimus on ex vivo expansion of CD34+CD38(-)-enriched cord blood cells
    S el Marsafy
    Laboratoire de Recherche sur la Biologie de la Moelle Osseuse, Institut Universitaire d Hematologie, EA 1814 Paris VII, Hopital Saint Louis, 1, avenue Claude Vellefaux, 75475 Paris, France
    Haematologia (Budap) 32:327-36. 2002
    ....
  3. ncbi request reprint Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia
    V Rocha
    Eurocord-Cord Blood Transplant Group (CBTG) and Biostatistics Department, Saint Louis Hospital AP-HP, University of Paris 7, France
    Blood 97:2962-71. 2001
    ..39; 95CI: 0.97-1.99; P <.07). In conclusion, the use of UCBT, as a source of hematopoietic stem cells, is a reasonable option for children with AL lacking an acceptably matched unrelated marrow donor...
  4. ncbi request reprint Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia
    J R Passweg
    Department Innere Medizin, Kantonsspital, Basel, Switzerland
    Bone Marrow Transplant 37:641-9. 2006
    ..Therefore, early referral for transplantation should be encouraged for patients who fail immunosuppressive therapy and have a suitable alternative donor...
  5. ncbi request reprint History of the clinical use of umbilical cord blood hematopoietic cells
    E Gluckman
    Department of Hematology, Bone Marrow Transplant and Eurocord Netcord Registry, Hospital Saint Louis, Paris, France
    Cytotherapy 7:219-27. 2005
    ..able to overcome the HLA barrier and authorize HLA-mismatched transplants? Is it possible to establish CB banks for unrelated and related transplants? What would be the criteria for collection, quality control and cryopreservation?..
  6. ncbi request reprint HLA-G mRNA forms in human trophoblasts and peripheral blood lymphocytes: potential use in prenatal diagnosis
    P Moreau
    CEA DSV DPTE, Laboratoire d Immunoradiobiologie, Hopital Saint Louis, Centre Hayem, Paris, France
    Folia Biol (Praha) 40:431-8. 1994
    ....
  7. ncbi request reprint Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders
    H Bittencourt
    Bone Marrow Transplant Unit, Hospital Saint Louis, Paris, France
    Bone Marrow Transplant 36:431-5. 2005
    ..02) and GVHD (P = 0.005) were associated with higher risk of death. In conclusion, hematological response after 3 days with G-CSF predicted a better survival for patients with PGF after allo-SCT...
  8. ncbi request reprint A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors
    M Robin
    Service d hématologie greffe de moelle, Hopital Saint Louis, APHP, Paris, Cedex, France
    Leukemia 19:1613-20. 2005
    ..We conclude that allogeneic transplantation with a related donor can cure more than half of CML patients in chronic phase, although physicians should be alert to long-term complications...
  9. ncbi request reprint Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients
    R Peffault de Latour
    Service d hématologie greffe de moelle osseuse, et Université Paris VII, Hopital Saint Louis, Paris Cedex, France
    Bone Marrow Transplant 36:709-13. 2005
    ..This study thus highlights the efficacy of combined therapy and emphasizes the fact that the undue safety concerns are not a problem when treating this particular population...
  10. ncbi request reprint Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry
    J Donadieu
    Service d hématologie et oncologie pédiatrique, Hopital Trousseau, Paris, France
    Bone Marrow Transplant 36:787-92. 2005
    ..The overall 5-year event-free survival rate is 60+/-15%. We conclude that HSCT is feasible for patients with SDS who develop bone marrow failure or malignant transformation...
  11. ncbi request reprint Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis
    J Larghero
    Cell Therapy Unit, Assistance Publique Hopitaux de Paris, Saint Louis Hospital, Paris, France
    Ann Rheum Dis 67:443-9. 2008
    ..Mesenchymal stem cells (MSCs) have a potential immunomodulatory role in autoimmune disease; however, the qualitative properties and haematopoietic support capacity of MSCs derived from patients with autoimmune disease is unclear...
  12. ncbi request reprint Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis
    M C Vonk
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, P O Box 9101, 6500 HB Nijmegen, The Netherlands
    Ann Rheum Dis 67:98-104. 2008
    ..This study reports the effects on survival, skin and major organ function of HSCT in patients with severe diffuse cutaneous SSc...
  13. ncbi request reprint Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome
    E Gluckman
    Hematology Department, Eurocord Hôpital, Saint Louis, Paris, France
    Bone Marrow Transplant 41:127-32. 2008
    ..In this review, we will report recent results of treatment of Fanconi anemia and other hereditary BMF syndromes...
  14. ncbi request reprint EBV transformation of cells from cord blood donations: relevance to future retrospective studies on cord blood transplants
    X N Wang
    Bone Marrow Transplant 35:619-21. 2005
  15. pmc Chronic diarrhoea after allogenic bone marrow transplantation
    B Radu
    Service de Gastroenterologie, Hopital Saint Louis, 1 avenue Claude Vellefaux, F75010, Paris, France
    Gut 54:161, 174. 2005
  16. pmc BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity
    A Bensussan
    Institut National de la Santé et de la Recherche Médicale Unité 93, Hopital Saint Louis, Paris, France
    Proc Natl Acad Sci U S A 91:9136-40. 1994
    ..Furthermore, we detected in cord blood no cytotoxic T lymphocyte activity but we demonstrated that the CD3-BY55+ cell subset contained the whole natural killer activity...
  17. pmc An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes
    M Kirszenbaum
    Commissariat a l Energie Atomique, Hôpital Saint Louis Centre Hayem, Paris, France
    Proc Natl Acad Sci U S A 91:4209-13. 1994
    ..These results are discussed in the context of the fetal-maternal relationship presented by HLA-G gene products...
  18. ncbi request reprint Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia
    R Morariu-Zamfir
    Laboratory of Cellular Therapy, Saint Louis Hospital, Paris, France
    Bone Marrow Transplant 27:575-80. 2001
    ..5 (95% CI: 1.09-5.75), P = 0.03) and a lower number of marrow CD34(+) cells infused/kg (HR: 4.55 (95% CI: 1.87-10.90), P = 0.0008)...
  19. pmc Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
    M Binks
    Royal Free Hospital, London
    Ann Rheum Dis 60:577-84. 2001
    ..If future trials incorporate inclusion and exclusion criteria based on this preliminary experience, the predicted procedure related mortality should be around 10%...
  20. ncbi request reprint Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    G Socie
    Service d hématologie greffe de moelle, Unité Propre d Enseignement Supérieur UPRES EA 2378 Université Paris VII, France
    Transplantation 72:699-706. 2001
    ..It is not known, however, whether these factors are independent of other clinically recognized risk factors such as age and disease stage...
  21. ncbi request reprint Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients
    S Maury
    Department of Haematology-Bone Marrow Transplant, , Paris, France
    Br J Haematol 115:630-41. 2001
    ....
  22. ncbi request reprint DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation
    P Loiseau
    Service d Immunologie et d Histocompatibilité, Hôpital Saint Louis AP, Paris, France
    Bone Marrow Transplant 30:497-502. 2002
    ..Our data indicate that the outcome of unrelated hematopoietic cell transplantation in terms of GVHD but also survival, could be improved through HLA-DPB1 matching or at least by avoiding two DPB1 mismatches...
  23. ncbi request reprint Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia
    O Ringden
    Centre for Allogeneic Stem Cell Transplantation, Huddinge, Sweden
    J Clin Oncol 20:4655-64. 2002
    ..However, the data are inconsistent with regard to acute and chronic graft-versus-host disease (GVHD), relapse, transplant-related mortality (TRM), and leukemia-free survival (LFS)...
  24. ncbi request reprint Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality
    M Robin
    Haematology Department, Bone Marrow Transplant Unit, Hospital Saint Louis, Paris, France
    Bone Marrow Transplant 31:877-87. 2003
    ..The analysis strongly suggests that the combination of pretransplant factors such as chemotherapy and conditioning, and posttransplant factors such as chronic GvHD had a major impact on late nonrelapse morbidity and mortality...
  25. ncbi request reprint Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register
    C Ferry
    Service de Transplantation médullaire, Hopital St Louis, Paris, France
    Bone Marrow Transplant 35:45-50. 2005
    ....
  26. doi request reprint Indications and results of cord blood transplant in children with leukemia
    E Gluckman
    Eurocord Hematology Department, APHP University Paris VII, Paris, France
    Bone Marrow Transplant 41:S80-2. 2008
    ..In conclusion, UCB is a valuable alternative source of hematopoietic stem cell transplantation in children with acute leukemia who need an allogeneic transplant, but lack a suitable sibling donor...